GW Pharmaceuticals Gets Orphan Drug Status For Cannabidiol, Stock Rises
April 21, 2016 at 09:58 AM EDT
GW Pharmaceuticals PLC (NASDAQ: GWPH) disclosed that FDA has accorded Orphan Drug Designation for its Cannabidiol for the treatment ...